STOCK TITAN

Docusign Form 4 Filings

DOCU NASDAQ

Every Form 4 that Docusign (DOCU) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow DOCU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DOCU filings page.

Rhea-AI Summary

DOCUSIGN, INC. reported that its Chief Financial Officer, Blake Jeffrey Grayson, sold shares of the company’s common stock in open-market transactions. On September 4, 2026, he sold 30,000 shares at a reported price of $70.00 per share. On September 8, 2026, he sold 11,550 shares at $65.25 per share and 3,450 shares at $66.64 per share, for a total of 45,000 shares sold. All sales were made pursuant to a Rule 10b5-1 plan, and the reported prices for two of the transactions are accompanied by ranges indicating the shares were sold at prices within the stated intervals.

Rhea-AI Summary

DOCUSIGN, INC. (DOCU) director Brian Keith Roberts reported the exercise of 856 Restricted Stock Units (RSUs) into 856 shares of Common Stock on September 5, 2026, at a stated price of $0.00 per share. Following this conversion, he held 1,711 shares of Common Stock directly.

The exercised RSUs each represent a contingent right to receive one share of DOCU common stock. After this transaction, Roberts also held 8,558 RSUs, which are scheduled to vest in twelve equal quarterly installments over three years, with a vesting commencement date of March 5, 2026, subject to his continued service. The RSUs do not have an expiration date; they either vest or are canceled. No Rule 10b5-1 trading plan is reported for these transactions.

Rhea-AI Summary

DOCUSIGN, INC. (DOCU) reported that its Chief Financial Officer, Blake Jeffrey Grayson, sold a total of 45,000 shares of common stock in open-market transactions. The sales occurred on September 4, 2026 and September 8, 2026, and were affirmed as made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

DOCUSIGN, INC. (DOCU) director Enrique T Salem reported the exercise and conversion of 1,096 Restricted Stock Units into 1,096 shares of common stock on September 1, 2026, at a stated price of $0.00 per share. Following the transactions, he holds 168,414 common shares and 3,288 RSUs directly. Each RSU represents a contingent right to receive one share of common stock, with the RSUs vesting in equal quarterly installments over one year starting June 1, 2026, subject to continued service. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

DOCUSIGN, INC. (DOCU) director Michael George Rosenbaum reported the exercise of 522 Restricted Stock Units into an equal number of shares of common stock on September 3, 2026. Following this RSU conversion, he holds 2,088 common shares and 4,177 RSUs directly. The RSUs vest in twelve equal quarterly installments over three years starting September 3, 2025, and either vest or are canceled; no Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

Docusign, Inc. (DOCU) reported that director Peter Solvik had 1,096 Restricted Stock Units convert into the same number of shares of common stock on September 1, 2026 at $0.00 per share. Following this event, he holds 10,066 shares of common stock directly, plus additional indirect holdings through various trusts, a family partnership, and a spouse, and 3,288 RSUs remain outstanding. The RSUs vest in equal quarterly installments over one year starting June 1, 2026, subject to his continued service, and either vest or are canceled; they do not expire. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

DOCUSIGN, INC. (DOCU) director Teresa Briggs reported equity compensation activity on September 1, 2026. She was granted 1,096 Restricted Stock Units (RSUs), each representing a contingent right to one share of common stock, bringing her RSU holdings to 3,288 units. On the same date, she acquired 1,096 shares of common stock at a reported price of $0.00 per share through the exercise or conversion of a derivative security, resulting in 11,359 common shares held directly. The RSUs begin vesting June 1, 2026 in equal quarterly installments over one year, subject to her continued service, and do not expire but either vest or are canceled.

Rhea-AI Summary

DOCUSIGN, INC. (DOCU) director Blake Irving reported the vesting and conversion of 1,096 Restricted Stock Units into 1,096 shares of common stock on September 1, 2026. Each RSU represents a contingent right to receive one common share, and the RSUs either vest or are canceled rather than expiring.

After this transaction, Irving directly holds 3,288 RSUs and 27,189 shares of DOCUSIGN common stock. The filing indicates the RSUs vest in equal quarterly installments over one year starting June 1, 2026, subject to continued service, and no Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

DOCUSIGN, INC. (DOCU) director James A. Beer reported the vesting and settlement of 1,096 Restricted Stock Units into an equal number of shares of common stock on September 1, 2026, at no cash exercise price. After these transactions he holds 15,682 shares directly, 3,288 RSUs, and 5,543 shares indirectly through a trust. The RSUs vest in equal quarterly installments over one year starting June 1, 2026, subject to continued service and the timing conditions described.

Rhea-AI Summary

DOCUSIGN, INC. (DOCU) director Mary Agnes Wilderotter reported the conversion of 1,096 Restricted Stock Units into 1,096 shares of common stock on September 1, 2026, at no cash exercise price. After this event she holds 4,295 common shares directly and 57,333 shares indirectly through a family trust. The reported Restricted Stock Units represent the right to receive one share each, vesting in equal quarterly installments over one year starting June 1, 2026, subject to continued service, and are either vested or canceled rather than expiring. No Rule 10b5-1 trading plan is reported for these transactions.

Rhea-AI Summary

DOCUSIGN, INC. (DOCU) director Cain A. Hayes reported the vesting and conversion of 1,096 Restricted Stock Units into an equal number of shares of common stock on September 1, 2026. Following these transactions, Hayes holds 3,288 RSUs and 16,813 shares of common stock directly. Each RSU represents a contingent right to receive one share of common stock, with vesting in equal quarterly installments over one year starting June 1, 2026, subject to continued service.

Rhea-AI Summary

DOCUSIGN, INC. (DOCU) director Anna Marrs reported an automatic conversion of equity awards on September 1, 2026. A block of 1,096 Restricted Stock Units converted into 1,096 shares of Common Stock, reflecting vesting of previously granted RSUs rather than an open‑market trade. After these transactions, she holds 3,288 RSUs and 14,073 shares of Common Stock, all as direct ownership. The company indicates these RSUs vest in equal quarterly installments over one year starting June 1, 2026, subject to continued service, and no Rule 10b5‑1 trading plan is reported for these transactions.

Rhea-AI Summary

DOCUSIGN, INC. (DOCU) director James A. Beer reported selling 450 shares of common stock on 2026-08-28 at $64.02 per share in an open-market or private transaction executed under a Rule 10b5-1 trading plan. After this sale, he directly holds 14,586 shares and indirectly holds 5,543 shares through a trust.

Rhea-AI Summary

DOCUSIGN, INC. Chief Financial Officer Blake Jeffrey Grayson sold 15,000 shares of common stock on 2026-08-07 at $60.00 per share in an open market or private transaction. Following the sale, he directly holds 126,429 shares of common stock. The sale was effected under a Rule 10b5-1 trading plan previously adopted by the reporting person.

Rhea-AI Summary

Rowan M. Trollope, a director of DocuSign, Inc., reported exercising 869 restricted stock units into 869 shares of common stock at $0.00 per share on August 2, 2026. Following the transaction, he holds 869 common shares directly and 9,569 restricted stock units.

Rhea-AI Summary

Thygesen Allan C. reported acquisition or exercise transactions in this Form 4 filing.

DOCUSIGN, INC. reported equity compensation grants to President and CEO Allan C. Thygesen. He received 182,366 restricted stock units that vest in equal quarterly installments over three years starting on May 10, 2026, and 273,548 performance stock units that may vest based on subscription revenue and free cash flow goals over the FY29 Financial Performance Period, with any achieved PSUs vesting on June 10, 2029 and each unit representing one share of common stock.

Rhea-AI Summary

Shaughnessy James P reported acquisition or exercise transactions in this Form 4 filing.

DOCUSIGN, INC. Chief Legal Officer James P. Shaughnessy reported equity compensation awards in the form of performance stock units (PSUs) and restricted stock units (RSUs). He received two PSU grants of 24,777 units each and one RSU grant of 49,555 units, each unit representing a contingent right to one share of common stock. The RSUs vest in equal quarterly installments over three years starting on May 10, 2026, subject to continued service. The PSUs vest based on subscription revenue and free cash flow goals over the FY29 Financial Performance Period, with up to 200% of target potentially vesting and any achieved PSUs vesting on June 10, 2029, subject to continued service.

Rhea-AI Summary

Chatwani Robert reported acquisition or exercise transactions in this Form 4 filing.

DOCUSIGN, INC. reported that President and General Manager, Growth, Robert Chatwani received equity-based compensation on July 9, 2026. The awards include multiple grants of 37,166 Performance Stock Units (PSUs) each and 74,333 Restricted Stock Units (RSUs), all at a price of $0.00 per unit. Each RSU and PSU represents a contingent right to receive one share of common stock, subject to service and performance-based vesting conditions extending through the FY29 performance period.

Rhea-AI Summary

Hansen Paula reported acquisition or exercise transactions in this Form 4 filing.

DOCUSIGN, INC. reported that Chief Revenue Officer Paula Hansen received equity awards consisting of 44,600 performance stock units in two separate grants and 89,200 restricted stock units on July 9, 2026. The RSUs vest in equal quarterly installments over three years starting May 10, 2026. The PSUs vest based on subscription revenue and free cash flow goals over a three-year FY29 Financial Performance Period, with any earned PSUs vesting on June 10, 2029 and capped at 200% of target.

Rhea-AI Summary

GRAYSON BLAKE JEFFREY reported acquisition or exercise transactions in this Form 4 filing.

Docusign, Inc. reported equity awards to Chief Financial Officer Grayson Blake Jeffrey. On July 9, 2026, he received two grants of 44,600 Performance Stock Units each and a grant of 89,200 Restricted Stock Units, all at a price of $0.00 per unit. Each RSU represents one share of common stock and vests in equal quarterly installments over three years starting May 10, 2026, subject to continued service. The PSUs each represent one share of common stock and may vest based on subscription revenue and free cash flow goals over the three-year FY29 Financial Performance Period, with maximum vesting capped at 200% of target and any earned PSUs vesting on June 10, 2029, subject to continued service.

Rhea-AI Summary

DOCUSIGN, INC. Chief Revenue Officer Paula Hansen reported an open-market sale of 6,000 shares of common stock at a weighted average price of $45.54 per share. The filing shows she now directly holds 89,972 shares of DocuSign common stock after this transaction.

The sale was carried out under a pre-arranged Rule 10b5-1 trading plan, meaning the trades were scheduled in advance rather than timed discretionarily. Footnotes note the shares were sold in multiple trades at prices ranging from $44.99 to $45.95 per share.

Rhea-AI Summary

DocuSign, Inc. Chief Financial Officer Blake Jeffrey Grayson reported open-market sales of a total of 15,000 shares of Common Stock on July 1, 2026. The sales were executed at prices ranging from about $44.95 to $46.04, under a pre-arranged Rule 10b5-1 trading plan.

After these transactions, Grayson continues to hold 141,429 shares of DocuSign Common Stock directly. Because the trades were made pursuant to a Rule 10b5-1 plan, they appear to be part of a scheduled diversification or liquidity program rather than a discretionary timing decision.

Rhea-AI Summary

DocuSign, Inc. Chief Legal Officer James P. Shaughnessy reported open-market sales of company stock. On July 1, 2026, he sold a total of 12,000 shares of DocuSign common stock in two transactions under a pre-arranged Rule 10b5-1 trading plan.

One trade covered 11,754 shares at a reported price of $45.53 per share, and another covered 246 shares at $46.01 per share. Footnotes state the shares were actually sold in multiple trades at prices ranging from $44.95 to $45.92 and from $45.99 to $46.03, with full price-by-trade details available on request.

Rhea-AI Summary

DocuSign, Inc. President and CEO Allan C. Thygesen reported selling a total of 26,250 shares of Common Stock in open-market transactions on July 1, 2026. The sales were executed in two tranches of 21,993 and 4,257 shares at prices ranging from $44.96 to $46.35 per share. The transactions were carried out under a pre-arranged Rule 10b5-1 trading plan, indicating they were scheduled in advance rather than timed discretionarily.

Rhea-AI Summary

DocuSign, Inc. president and general manager of growth Robert Chatwani reported selling a total of 15,902 shares of common stock in open-market transactions. The sales, made under a pre-arranged Rule 10b5-1 trading plan, were executed at prices around the low-to-mid $40s per share, and he continues to hold 72,805 shares directly.

Rhea-AI Summary

DOCUSIGN, INC. executive Robert Chatwani reported routine equity compensation activity. On June 15, 2026, he exercised awards that delivered 31,543 shares of common stock, primarily from restricted stock units and performance stock units converting into shares.

On the same date, 15,641 shares were withheld by the company to cover tax obligations from these vesting events, rather than being sold in the market. A prior entry shows an earlier grant of 346 shares of common stock on April 3, 2026 under the employee stock purchase plan.

Following these transactions, Chatwani directly holds 104,347 shares of DOCUSIGN common stock. The footnotes explain that RSUs and PSUs vest over several years based on continued service and, for PSUs, on subscription revenue and free cash flow performance targets.

Rhea-AI Summary

DocuSign President and CEO Allan C. Thygesen reported routine equity compensation activity. On June 15, 2026, he exercised performance stock units and restricted stock units that each convert into one share of common stock, adding to his direct holdings.

As part of the same event, 32,510 shares of common stock were withheld by DocuSign to cover tax obligations triggered by the vesting of these awards, rather than being sold in the open market. Following these transactions, Thygesen directly owned 185,288 shares of common stock, reflecting compensation-related vesting and associated tax withholding, not discretionary buying or selling.

Rhea-AI Summary

Docusign Chief Revenue Officer Paula Hansen reported several equity compensation transactions. On June 15, 2026, she exercised or vested equity awards covering 32,516 shares of common stock from restricted stock units and performance stock units, and 16,123 shares of common stock were withheld to cover tax obligations on these vestings. After one of the June 15 transactions, she directly held 95,972 shares of Docusign common stock. Earlier, on April 3, 2026, she also acquired 346 shares under the company’s Employee Stock Purchase Plan at a purchase price of $41.11 per share.

Rhea-AI Summary

DOCUSIGN, INC. Chief Legal Officer James P. Shaughnessy reported routine equity compensation activity. On June 15, 2026, he exercised derivative awards, including restricted stock units and performance stock units, into common stock and had 9,788 shares withheld to cover tax obligations.

These transactions increased his direct common stock position through option and unit exercises while using shares, rather than cash, to satisfy taxes. Following the transactions, he directly holds 64,815 shares of DocuSign common stock.

Rhea-AI Summary

DOCUSIGN, INC. Chief Financial Officer Jeffrey Blake Grayson reported a set of routine equity compensation transactions. On June 15, 2026, he exercised or converted multiple restricted stock unit (RSU) and performance stock unit (PSU) awards into common stock, including blocks of 23,141, 5,186, 5,119, 2,347, and 1,659 shares.

On the same date, 15,251 common shares were withheld by DocuSign to cover tax obligations triggered by RSU and PSU vesting, a non-market disposition that did not involve an open-market sale. One line in the filing shows 156,429 common shares held directly after this tax withholding entry.

The filing also notes a prior acquisition of 255 common shares on April 3, 2026 through DocuSign’s 2018 Employee Stock Purchase Plan at $41.11 per share, purchased at 85% of the stock’s closing price under the plan’s terms.

Rhea-AI Summary

DOCUSIGN, INC. director Brian Keith Roberts reported a compensation-related equity transaction involving restricted stock units. On June 5, 2026, 855 restricted stock units converted into 855 shares of common stock, leaving him with 855 common shares held directly.

The filing also shows 9,414 restricted stock units outstanding after the transaction. Each restricted stock unit represents a contingent right to receive one share of common stock and will vest in twelve equal quarterly installments over three years, starting on March 5, 2026, as long as Roberts remains a service provider. The units do not expire; they either vest or are canceled before vesting.

Rhea-AI Summary

DocuSign director Anna Marrs reported an option exercise and a small share sale. On June 4, 2026, she exercised 725 restricted stock units, converting them into 725 shares of common stock at an exercise price of $0.00 per share. On June 5, 2026, she then executed an open-market sale of 363 common shares at $49.42 per share under a pre-arranged Rule 10b5-1 trading plan, leaving her with 12,977 common shares held directly after the transactions.

Rhea-AI Summary

DOCUSIGN, INC. director Michael George Rosenbaum exercised restricted stock units into common shares. He acquired 522 shares of common stock through the conversion of 522 restricted stock units at a reported price of $0.0000 per share, with no shares sold in these transactions.

Following the exercise, he directly holds 1,566 shares of common stock and 4,699 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock, and the units vest in twelve equal quarterly installments over three years, subject to continued service.

Rhea-AI Summary

DocuSign director Enrique T. Salem reported equity compensation activity. He received a grant of 4,384 restricted stock units (RSUs), each representing one share of common stock, vesting in equal quarterly installments over one year, tied to continued service.

On a separate date, he exercised 729 RSUs into 729 shares of common stock at no exercise price and did not report any same-day sale. After these transactions, he directly holds 167,318 shares of DocuSign common stock.

Rhea-AI Summary

DOCUSIGN, INC. director Teresa Briggs reported a mix of equity compensation and routine trading activity. She received a grant of 4,384 restricted stock units, each representing one share of common stock, which will vest in equal quarterly installments over one year, subject to continued service. On the same filing, she exercised 729 RSUs into common stock and sold 365 common shares at $50.04 per share in an open-market transaction executed under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, she holds 10,263 common shares directly.

Rhea-AI Summary

DOCUSIGN, INC. director Mary Agnes Wilderotter reported routine equity compensation and estate-planning moves. She received a grant of 4,384 restricted stock units (RSUs) on June 1, 2026, each representing one share of common stock, vesting in equal quarterly installments over one year subject to continued service.

On May 29, 2026, she exercised 729 RSUs into 729 shares of common stock, bringing her directly held common stock to 3,199 shares. Earlier, on April 2, 2026, she made a bona fide gift of 57,333 shares of common stock to the Wilderotter Family Trust for no consideration. She serves as trustee, and she and her immediate family are the sole beneficiaries, so she continues to be the beneficial owner of those trust-held shares.

Rhea-AI Summary

DOCUSIGN director Peter Solvik reported equity compensation and a routine option-style exercise. On June 1, 2026, he received a grant of 4,384 Restricted Stock Units, each representing one share of common stock, vesting quarterly over one year starting on that date, subject to continued service.

On May 29, 2026, Solvik exercised 729 RSUs for 729 shares of common stock at an exercise price of $0.00, bringing his directly held common stock to 8,970 shares. The filing also lists indirect holdings, including 6,458 shares held by his spouse, 65,558 shares held by children’s trusts, 120,253 shares held by a trust, and 3 shares held by a family partnership. No open-market purchases or sales were reported.

Rhea-AI Summary

DOCUSIGN, INC. director Cain A. Hayes reported routine equity compensation activity. On June 1, 2026, Hayes received a grant of 4,384 Restricted Stock Units (RSUs), each representing a right to one share of common stock, vesting quarterly over one year subject to continued service.

On May 29, 2026, Hayes exercised a prior RSU award, converting 729 RSUs into an equal number of common shares. Following these transactions, Hayes directly holds 15,717 shares of common stock and 4,384 RSUs, with no reported stock sales in this filing.

Rhea-AI Summary

DocuSign director Irving Blake reported equity compensation activity. Blake received a grant of 4,384 restricted stock units (RSUs), each representing a contingent right to one share of DocuSign common stock. These RSUs have a vest commencement date of June 1, 2026 and will vest in equal quarterly installments over one year, with the final tranche vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to continued service.

On May 29, 2026, 729 RSUs were exercised and converted into 729 shares of common stock, reflecting a derivative exercise rather than an open-market purchase. Following this transaction, Blake directly held 26,093 shares of DocuSign common stock. The RSUs do not expire; they either vest or are canceled before vesting, so these transactions primarily reflect routine director compensation and vesting mechanics.

Rhea-AI Summary

DocuSign director James A. Beer reported mixed equity activity, including a small open-market sale and routine equity awards. He sold 450 shares of common stock on June 2, 2026 at $55.04 per share in an open-market transaction under a pre-arranged Rule 10b5-1 plan, leaving him with 15,036 directly held shares. On May 29, 2026, 729 Restricted Stock Units (RSUs) converted into 729 shares of common stock as they vested. He also holds 5,543 shares indirectly through a trust. On June 1, 2026, he received a grant of 4,384 RSUs, each representing a right to one share of common stock, scheduled to vest in equal quarterly installments over one year, subject to continued service and the timing of the company’s next annual stockholder meeting.

Rhea-AI Summary

DOCUSIGN, INC. director Anna Marrs reported a mix of equity compensation and routine trading activity. She sold 365 shares of common stock on June 2, 2026 at $55.04 per share under a pre-arranged Rule 10b5-1 trading plan, and held 12,615 common shares afterward.

On May 29, 2026, 729 Restricted Stock Units (RSUs) were exercised into 729 common shares, fully settling that RSU lot. On June 1, 2026, she received a grant of 4,384 RSUs, each representing one future share of common stock, vesting quarterly over one year based on continued service.

Rhea-AI Summary

Trollope Rowan M reported acquisition or exercise transactions in this Form 4 filing.

DOCUSIGN, INC. director Rowan M. Trollope received a grant of 10,438 restricted stock units on May 8, 2026. Each RSU represents a contingent right to receive one share of DocuSign common stock.

The 10,438 RSUs will vest in twelve equal quarterly installments over three years, starting on May 2, 2026, as long as Trollope remains a service provider through each vesting date. The RSUs do not expire; they either vest into common shares or are canceled before vesting.

Rhea-AI Summary

DOCUSIGN, INC. director Mary Agnes Wilderotter exercised stock options and sold shares in a routine transaction. She exercised options for 3,000 shares of Common Stock at an exercise price of $17.66 per share, then sold 3,000 shares at $48.15 per share on the same date.

After these transactions, she directly held 59,803 shares of DocuSign common stock. The derivative position tied to this specific option grant was fully exercised, with no remaining options from this grant shown in the filing.

Rhea-AI Summary

DOCUSIGN, INC. Chief Revenue Officer Paula Hansen reported open-market sales of 6,000 shares of common stock on April 1, 2026. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, with sale prices ranging from about $45.85 to $48.00 per share. Following these sales, Hansen directly holds 79,233 shares of DocuSign common stock, indicating she retained a substantial equity position after the trades.

Rhea-AI Summary

DOCUSIGN, INC. Chief Legal Officer James P. Shaughnessy reported selling a total of 12,000 shares of common stock in open-market transactions on April 1, 2026. The sales included 5,419 shares at $46.22, 6,481 shares at $47.33, and 100 shares at $48.00 per share. These transactions were executed under a pre-arranged Rule 10b5-1 plan, and following the sales he directly holds 53,631 shares of DocuSign common stock.

Rhea-AI Summary

DOCUSIGN, INC. President and CEO Allan C. Thygesen sold 26,250 shares of Common Stock in three open-market transactions on April 1 pursuant to a pre-arranged Rule 10b5-1 plan. Sale prices ranged from about $45.89 to $48.38 per share, and he continues to hold 152,237 shares directly.

Rhea-AI Summary

Roberts Brian Keith reported acquisition or exercise transactions in this Form 4 filing.

DocuSign director Brian Keith Roberts received a grant of 10,269 restricted stock units (RSUs). Each RSU represents the right to receive one share of DocuSign common stock. The award will vest in twelve equal quarterly installments over three years starting on March 5, 2026, as long as he remains a service provider. The RSUs have no traditional expiration date; they either vest on schedule or are canceled if vesting conditions are not met.

Rhea-AI Summary

DocuSign, Inc. executive Robert Chatwani reported selling 16,696 shares of Common Stock in open-market transactions. The sales took place on March 18, 2026 at prices reported around $45.52 to $49.50 per share. After these trades, he directly holds 72,458 DocuSign shares. The filing notes the transactions were carried out under a pre-arranged Rule 10b5-1 trading plan, indicating they were scheduled in advance rather than timed discretionarily.

Rhea-AI Summary

DOCUSIGN, INC. executive Robert Chatwani reported equity compensation activity, not open‑market trading. On March 15, 2026, he exercised and settled restricted stock units (RSUs) and performance stock units (PSUs) that convert into common stock on a one‑for‑one basis at an exercise price of $0.00 per share.

These settlements delivered 31,541 shares of common stock, while 12,584 shares were withheld by DocuSign to cover tax obligations tied to the vesting, as described in the footnotes. After these transactions, Chatwani directly owns 89,154 shares of DocuSign common stock. The RSUs and PSUs vest over multi‑year schedules and, for PSUs, depend on subscription revenue and free cash flow performance for specified fiscal periods.

Rhea-AI Summary

Docusign, Inc. President and CEO Allan C. Thygesen reported multiple equity award vestings and conversions on March 15, 2026. He exercised restricted stock units and performance stock units into 65,560 shares of common stock. To cover tax obligations on these vestings, 29,334 shares were withheld by the company, a non-market disposition.

Following these transactions, Thygesen directly holds 178,487 shares of Docusign common stock. The RSUs vest in quarterly installments over four-year schedules starting on October 10, 2022, May 10, 2023, May 10, 2024, and May 10, 2025. The PSUs vest based on Docusign’s subscription revenue and free cash flow performance for the FY24 and FY25 performance periods, with potential vesting up to 200% of target if performance conditions are fully achieved.